For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260109:nRSI3625Oa&default-theme=true
RNS Number : 3625O GreenX Metals Limited 09 January 2026
NEWS RELEASE 9 JANUARY 2026
Singapore Court dismisses Poland's application to set-aside GreenX's ECT Award
GreenX Metals Limited (GreenX or Company) is pleased to announce that the
Singapore International Commercial Court of the Republic of Singapore
(Singapore Court) has rejected, in its entirety, the Republic of Poland's
(Poland) application to set aside the Energy Charter Treaty (ECT) award,
thereby upholding GreenX's previously announced right to compensation under
the ECT.
· As previously advised, in October 2024, GreenX was
awarded approximately £252 million (A$519 million / PLN 1.2 billion) in
compensation and interest in the Australia-Poland Bilateral Investment Treaty
(BIT) award after the Tribunal unanimously held that Poland breached its
obligations under the BIT and ECT.
· At the time, approximately £183 million (A$378 million
/ PLN 900 million) was awarded pursuant to the ECT (with payments under one
award offset against the other).
· In 2025, Poland lodged a request to set-aside the ECT
award in the Singapore Court (having also lodged a request to set-aside the
BIT award in the courts of England and Wales in late 2024). The hearing for
the ECT set-aside was held in the Singapore Court in July 2025.
· The Singapore Court has issued a judgment whereby it has
rejected, in its entirety, Poland's application to set aside the ECT award.
· Additional interest of approximately £17 million (A$34
million / PLN 83 million) has already accrued from when the Award was made in
October 2024 to end of December 2025 and will continue to compound annually
until full and final payment by Poland.
In January 2025 Poland lodged a request to set-aside the ECT award in the
Singapore Court challenging jurisdictional aspects of the ECT award and
alleged procedural unfairness in the Tribunal's decision on damages.
GreenX advises that the Singapore Court has now issued a judgment whereby it
has rejected, in its entirety, Poland's application to set aside the ECT
award.
A redacted judgment has been released by the Singapore Court. The Company
intends to bring the judgment to the attention of the English courts as part
of the BIT set-aside proceedings. Poland has the right to apply to the
Singapore courts to appeal the dismissal of the ECT set-aside motion, however
if an appeal is granted, it is expected that such an appeal would be dealt
with expeditiously by the relevant Singapore court with Poland then having no
further rights of appeal. The threshold to succeed on a set aside motion in
either the Singapore or English courts is very high, with the courts rejecting
set-aside applications in the vast majority of cases.
The Company will continue to defend its awards and update the market in line
with its continuous disclosure requirements.
ENQUIRIES
Ben Stoikovich
Chief Executive Officer
+44 207 478 3900
Forward Looking Statements
This release may include forward-looking statements. These forward-looking
statements are based on GreenX's expectations and beliefs concerning future
events. Forward looking statements are necessarily subject to risks,
uncertainties and other factors, many of which are outside the control of
GreenX, which could cause actual results to differ materially from such
statements. GreenX makes no undertaking to subsequently update or revise the
forward-looking statements made in this release, to reflect the circumstances
or events after the date of that release.
This announcement has been authorised for release by the Company's Chief
Executive Officer, Mr Ben Stoikovich.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCUKAARNOUARAR
Copyright 2019 Regulatory News Service, all rights reserved